Carbonic Anhydrases inhibitory effects of new benzenesulfonamides synthesized by using superacid chemistry

Journal of Enzyme Inhibition and Medicinal Chemistry

Volumn 27, Issue 6, 2012, Pages 886-891

  Liu, Fei ^a   Martin Mingot, Agnès ^a   Lecornue F ^a   Jouannetaud, Marie Paule ^a   Maresca, Alfonso ^b   Thibaudeau, Sebastien ^a   Supuran, Claudiu T ^b  

^a UMR 6514   (France)

^b UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Fluorine chemistry; Hypoxic tumors; Sultams; Superelectrophiles

Indexed keywords

ANTIMONY DERIVATIVE; BENZENESULFONAMIDE DERIVATIVE; CARBONATE DEHYDRATASE I; CARBONATE DEHYDRATASE II; CARBONATE DEHYDRATASE IX; CARBONATE DEHYDRATASE XII; CHLORTALIDONE; FLUORINE DERIVATIVE; FUROSEMIDE; HYDROFLUORIC ACID; INDAPAMIDE; ISOENZYME;

ARTICLE; CRYSTAL STRUCTURE; DRUG SYNTHESIS; ENZYME INHIBITION; FLUORINATION; PRIORITY JOURNAL; STEREOSPECIFICITY; STRUCTURE ACTIVITY RELATION;

ANTIMONY; CARBONIC ANHYDRASE INHIBITORS; CARBONIC ANHYDRASES; FLUORIDES; HALOGENATION; HUMANS; HYDROFLUORIC ACID; ISOENZYMES; KINETICS; MAGNETIC RESONANCE SPECTROSCOPY; NEOPLASM PROTEINS; SOLUTIONS; SULFONAMIDES;

EID: 84870516777     PISSN: 14756366     EISSN: 14756374     Source Type: Journal    
DOI: 10.3109/14756366.2011.638921     Document Type: Article

References (32)

1. Supuran CT. Carbonic anhydrases: Novel therapeutic applications for inhibitors and activators. Nat Rev Drug Discov 2008;7:168-181.
2. Supuran CT. Carbonic Anhydrases as Drug Targets - General Presentation. In: Supuran CT, Winum JY, (eds). Drug Design of Zinc- Enzyme Inhibitors: Functional, Structural, and Disease Applications. Hoboken, NJ: Wiley; 2009. pp 15-38.
3. Winum JY, Rami M, Scozzafava A, Montero JL, Supuran C. Carbonic anhydrase IX: A new druggable target for the design of antitumor agents. Med Res Rev 2008;28:445-463.
4. Supuran CT, Scozzafava A, Casini A. Carbonic anhydrase inhibitors. Med Res Rev 2003;23:146-189.
5. Thiry A, Dogné JM, Masereel B, Supuran CT. Targeting tumorassociated carbonic anhydrase IX in cancer therapy. Trends Pharmacol Sci 2006;27:566-573.
6. Supuran CT, Scozzafava A. Carbonic anhydrases as targets for medicinal chemistry. Bioorg Med Chem 2007;15:4336-4350.
7. Supuran CT. Carbonic anhydrase inhibition/activation: Trip of a scientist around the world in the search of novel chemotypes and drug targets. Curr Pharm Des 2010;16:3233-3245.
8. Rami M, Maresca A, Smaine FZ, Montero JL, Scozzafava A, Winum JY et al. Sulfonamides incorporating boroxazolidone moieties are potent inhibitors of the transmembrane, tumor-associated carbonic anhydrase isoforms IX and XII. Bioorg Med Chem Lett 2011;21:2975-2979.
9. Capkauskaite E, Baranauskiene L, Golovenko D, Manakova E, Gražulis S, Tumkevicius S et al. Indapamide-like benzenesulfonamides as inhibitors of carbonic anhydrases I, II, VII, and XIII. Bioorg Med Chem 2010;18:7357-7364.
10. Mader P, Brynda J, Gitto R, Agnello S, Pachl P, Supuran CT et al. Structural basis for the interaction between carbonic anhydrase and 1,2,3,4-tetrahydroisoquinolin-2-ylsulfonamides. J Med Chem 2011;54:2522-2526.
11. Mincione F, Benedini F, Biondi S, Cecchi A, Temperini C, Formicola G et al. Synthesis and crystallographic analysis of new sulfonamides incorporating NO-donating moieties with potent antiglaucoma action. Bioorg Med Chem Lett 2011;21:3216-3221.
12. Bertucci A, Innocenti A, Scozzafava A, Tambutté S, Zoccola D, Supuran CT. Carbonic anhydrase inhibitors. Inhibition studies with anions and sulfonamides of a new cytosolic enzyme from the scleractinian coral Stylophora pistillata. Bioorg Med Chem Lett 2011;21:710-714.
13. Supuran CT. Carbonic anhydrase inhibitors. Bioorg Med Chem Lett 2010;20:3467-3474.
14. Olah GA, Prakash GKS, Molnar A, Sommer J. Superacids, 2nd Edition. New York: Wiley; 2009.
15. Khalifah RG. The carbon dioxide hydration activity of carbonic anhydrase. I. Stop-flow kinetic studies on the native human isoenzymes B and C. J Biol Chem 1971;246:2561-2573.
16. Ilies MA, Vullo D, Pastorek J, Scozzafava A, Ilies M, Caproiu MT et al. Carbonic anhydrase inhibitors. Inhibition of tumor-associated isozyme IX by halogenosulfanilamide and halogenophenylaminobenzolamide derivatives. J Med Chem 2003;46:2187-2196.
17. Biswas S, Aggarwal M, Güzel Ö, Scozzafava A, McKenna R, Supuran CT. Conformational variability of different sulfonamide inhibitors with thienyl-acetamido moieties attributes to differential binding in the active site of cytosolic human carbonic anhydrase isoforms. Bioorg Med Chem 2011;19:3732-3738.
18. Jacquesy J-C. Organic Synthesis in Superacid. In: Olah GA, (ed). Carbocation Chemistry. New York: Wiley; 2009. pp 359-376.
19. Thibaudeau S, Martin-Mingot A, Jouannetaud M-P, Karam O, Zunino F. A novel, facile route to β-fluoroamines by hydrofluorination reaction in superacid HF-SbF5. Chem Commun 2007;3198-3200.
20. Vardelle E, Gamba-Sanchez D, Martin-Mingot A, Jouannetaud M-P, Thibaudeau S, Marrot J. Cyclisation/fluoriantion of nitrogen containing dienes in superacid HF-SbF5 : A new route to 3- and 4-fluoropiperidines. Chem Commun 2008;1473-1475.
21. Fahy J, Duflos A, Ribert J-P, Jacquesy J-C, Berrier C, Jouannetaud M-P, Zunino F. Vinca alkaloids in superacidic media: A method for creating a new family of antitumor derivatives. J Am Chem Soc 1997;119:8576-8577.
22. Debarge S, Thibaudeau S, Violeau B, Martin-Minfot A, Jouannetaud M-P, Jacquesy J-C, Cousson A. Rearrangement or gem-difluorination of quinine and 9-epiquinine and their acetates in superacid. Tetrahedron 2005;61:2065-2073.
23. Liu F, Martin-Mingot A, Jouannetaud MP, Zunino F, Thibaudeau S. Superelectrophilic activation in superacid HF/SbF(5) and synthesis of benzofused sultams. Org Lett 2010;12:868-871.
24. Olah GA, Klumpp D. Superelectrophiles and their chemistry. New York: Wiley; 2008.
25. Liu F, Musadji NY, Lecornué F, Jouannetaud M-P, Thibaudeau S. Superacid mediated reactions applied to 4-aminobenzofused sultams and fluorinated 4-aminobenzene sulfonamides synthesis. Tetrahedron 2010;66:7112-7118.
26. Thiry A, Supuran CT, Masereel B, Dogné JM. Recent developments of carbonic anhydrase inhibitors as potential anticancer drugs. J Med Chem 2008;51:3051-3056.
27. Alterio V, Hilvo M, Di Fiore A, Supuran CT, Pan P, Parkkila S et al. Crystal structure of the catalytic domain of the tumorassociated human carbonic anhydrase IX. Proc Natl Acad Sci USA 2009;106:16233-16238.
28. Vullo D, Scozzafava A, Pastorekova S, Pastorek J, Supuran CT. Carbonic anhydrase inhibitors: Inhibition of the tumor-associated isozyme IX with fluorine-containing sulfonamides. The first subnanomolar CA IX inhibitor discovered. Bioorg Med Chem Lett 2004;14:2351-2356.
29. O'Hagan D. Understanding organofluorine chemistry. An introduction to the C-F bond. Chem Soc Rev 2008;37:308-319.
30. Blackburn GM, Türkmen H. Synthesis of alpha-fluoro- and alpha, alpha-difluoro-benzenemethanesulfonamides: New inhibitors of carbonic anhydrase. Org Biomol Chem 2005;3:225-226.
31. Alterio V, Di Fiore A, D'Ambrosio K, Supuran CT, De Simone G. X-ray crystallography of ca inhibitors and its importance in drug design. In: Supuran CT, Winum JYed, . Drug Design of Zinc-Enzyme Inhibitors: Functional, Structural, and Disease Applications. Hoboken, NJ: Wiley; 2009. pp 73-138.
32. Neri D, Supuran CT. Interfering with pH regulation in tumours as a therapeutic strategy. Nat Rev Drug Discov 2011;10:767-777.